Brief: electrocore, Inc. Announces Study Of Gammacore Sapphire™ For The Treatment Of Post-Covid Syndrome
07/07/2022 13:04
July 7 (Reuters) - electroCore, Inc. ECOR.O :
* ELECTROCORE, INC. ANNOUNCES STUDY OF GAMMACORE SAPPHIRE™
FOR THE
TREATMENT OF POST-COVID SYNDROME
Source text for Eikon: ID:nGNX7n1D0Z
Further company coverage: ECOR.O
Recent news on electroCore
See all newselectroCore, Inc. reports results for the quarter ended June 30 - Earnings Summary
electroCore Q2 revenue jumps, but slightly misses estimates
Brief: electroCore Q2 Net Income USD -3.059 Million
electroCore, Inc. expected to post a loss of 42 cents a share - Earnings Preview
electroCore reiterates FY 2026 revenue guidance